Market Overview:
The global heart defect closure devices market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of congenital heart defects, technological advancements in closure devices, and rising awareness about heart diseases. Based on type, the global heart defect closure devices market is segmented into ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. ASDClosuredevices are expected to dominate the market due to their high usage rates for percutaneous interventions in children with congenital heart defects (CHDs).
Product Definition:
Heart defect closure devices are medical devices used to close a hole in the heart. They may be used either during or after surgery to repair a congenital heart defect.
ASD Closure Devices:
ASD closure devices, also known as heart defect closure devices or cardiac patching devices are used to close congenital holes in the heart. These defects can be caused due to infections during pregnancy or genetic mutations. The ASD closure device is a thin, soft silicone rubber sheet that is sewn into the skin overlying the affected area of the infant’s heart and held in place by strong adhesive material such as Dermabond.
VSD Closure Devices:
A VSD closure device is a surgical device used to close a ventricular septum in the heart. It works by creating and maintaining an airtight seal between the two chambers of the heart through flexible, thin, metal or plastic blades.
The primary function of this device is to prevent blood from entering into other body parts or getting carried away from where it’s needed in case of some sort of blockage in coronary arteries.
Application Insights:
The hospitals segment dominated the global market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to factors such as a high prevalence of cardiovascular diseases, increasing number of heart surgeries being performed, and rising awareness among individuals regarding open heart surgeries. According to data published by the World Health Organization (WHO) in 2018, out of all deaths caused by cardiovascular diseases globally around 1 in 3 deaths occur due to these diseases. In addition, according to WHO estimates published in 2019 around USD 618 billion is spent annually on Cardiovascular Diseases (CVDs) treatments worldwide which forms a major share of overall healthcare expenditure across various regions globally. These factors are anticipated to boost product demand from hospitals during the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high awareness levels coupled with a favorable reimbursement scenario. Moreover, increasing government funding for R&D activities and rising initiatives by private companies to develop novel technologies are expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare facilities & infrastructure and growing patient awareness regarding available heart defect closure devices. In addition, economic development in emerging countries such as China & India is further expected boost demand for these products during the forecast period.
Growth Factors:
- Increasing incidence of heart defects in children and adults
- Growing awareness about the benefits of heart defect closure devices
- Technological advancements in the field of heart defect closure devices
- Rising demand for minimally invasive procedures for heart defect closure
- increasing number of cardiac surgeons who are skilled in using heart defect closure devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Heart Defect Closure Devices Market Research Report
By Type
ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices, LAA Closure Devices
By Application
Hospitals, Clinics
By Companies
Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore and Associates, Starway, Coherex Medical, Cardia, MicroPort
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Heart Defect Closure Devices Market Report Segments:
The global Heart Defect Closure Devices market is segmented on the basis of:
Types
ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices, LAA Closure Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Boston Scientific
- LifeTech
- Lepu Medical
- Occlutech
- W. L. Gore and Associates
- Starway
- Coherex Medical
- Cardia
- MicroPort
Highlights of The Heart Defect Closure Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ASD Closure Devices
- VSD Closure Devices
- PDA Closure Devices
- PFO Closure Devices
- LAA Closure Devices
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heart Defect Closure Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heart defect closure devices are medical devices that help to close heart defects in infants and young children. These devices are inserted into the heart during surgery to help prevent future problems with the heart, such as arrhythmias (irregular heartbeat) and sudden death.
Some of the key players operating in the heart defect closure devices market are Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore and Associates, Starway, Coherex Medical, Cardia, MicroPort.
The heart defect closure devices market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heart Defect Closure Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Heart Defect Closure Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Heart Defect Closure Devices Market - Supply Chain
4.5. Global Heart Defect Closure Devices Market Forecast
4.5.1. Heart Defect Closure Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Heart Defect Closure Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Heart Defect Closure Devices Market Absolute $ Opportunity
5. Global Heart Defect Closure Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Heart Defect Closure Devices Market Size and Volume Forecast by Type
5.3.1. ASD Closure Devices
5.3.2. VSD Closure Devices
5.3.3. PDA Closure Devices
5.3.4. PFO Closure Devices
5.3.5. LAA Closure Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Heart Defect Closure Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Heart Defect Closure Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Heart Defect Closure Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Heart Defect Closure Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Heart Defect Closure Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Heart Defect Closure Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Heart Defect Closure Devices Demand Share Forecast, 2019-2026
9. North America Heart Defect Closure Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Heart Defect Closure Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Heart Defect Closure Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Heart Defect Closure Devices Market Size and Volume Forecast by Type
9.7.1. ASD Closure Devices
9.7.2. VSD Closure Devices
9.7.3. PDA Closure Devices
9.7.4. PFO Closure Devices
9.7.5. LAA Closure Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Heart Defect Closure Devices Demand Share Forecast, 2019-2026
10. Latin America Heart Defect Closure Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Heart Defect Closure Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Heart Defect Closure Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Heart Defect Closure Devices Market Size and Volume Forecast by Type
10.7.1. ASD Closure Devices
10.7.2. VSD Closure Devices
10.7.3. PDA Closure Devices
10.7.4. PFO Closure Devices
10.7.5. LAA Closure Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Heart Defect Closure Devices Demand Share Forecast, 2019-2026
11. Europe Heart Defect Closure Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Heart Defect Closure Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Heart Defect Closure Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Heart Defect Closure Devices Market Size and Volume Forecast by Type
11.7.1. ASD Closure Devices
11.7.2. VSD Closure Devices
11.7.3. PDA Closure Devices
11.7.4. PFO Closure Devices
11.7.5. LAA Closure Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Heart Defect Closure Devices Demand Share, 2019-2026
12. Asia Pacific Heart Defect Closure Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Heart Defect Closure Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Heart Defect Closure Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Heart Defect Closure Devices Market Size and Volume Forecast by Type
12.7.1. ASD Closure Devices
12.7.2. VSD Closure Devices
12.7.3. PDA Closure Devices
12.7.4. PFO Closure Devices
12.7.5. LAA Closure Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Heart Defect Closure Devices Demand Share, 2019-2026
13. Middle East & Africa Heart Defect Closure Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Heart Defect Closure Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Heart Defect Closure Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Heart Defect Closure Devices Market Size and Volume Forecast by Type
13.7.1. ASD Closure Devices
13.7.2. VSD Closure Devices
13.7.3. PDA Closure Devices
13.7.4. PFO Closure Devices
13.7.5. LAA Closure Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Heart Defect Closure Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Heart Defect Closure Devices Market: Market Share Analysis
14.2. Heart Defect Closure Devices Distributors and Customers
14.3. Heart Defect Closure Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LifeTech
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lepu Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Occlutech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. W. L. Gore and Associates
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Starway
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Coherex Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cardia
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. MicroPort
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
